Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with ALPS will be Presented at the 68th ASH Annual Meeting